Evaluation of MAGE-1 and MAGE-3 as Tumour-Specific Markers to Detect Blood Dissemination of Hepatocellular Carcinoma Cells

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6600016
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Anti-Tumor Immune Response Induced by a Combination of MAGE-3/MAGE-n-derived Peptides

Oncology Reports
MedicineCancer ResearchOncology
2008English

Erratum to “Intratumoral Heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 Expression in Mucosal Melanoma”

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2019English

Expression of MAGE-A12 in Oral Squamous Cell Carcinoma

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2008English

Clinical Evaluation of Urinary Transforming Growth Factor-Beta1 and Serum Alpha-Fetoprotein as Tumour Markers of Hepatocellular Carcinoma

British Journal of Cancer
Cancer ResearchOncology
1997English

CRMAGE: CRISPR Optimized MAGE Recombineering

Scientific Reports
Multidisciplinary
2016English

Human TH17 Immune Cells Specific for the Tumor Antigen MAGE-A3 Convert to IFN- -Secreting Cells as They Differentiate Into Effector T Cells in Vivo

Cancer Research
Cancer ResearchOncology
2012English

MAGE: A Distributed Programming Model

English

MAGE-A1 in Lung Adenocarcinoma as a Promising Target of Chimeric Antigen Receptor T Cells

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

A Neomorphic Cancer Cell-Specific Role of MAGE-A4 in Trans-Lesion Synthesis

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy